Suzhou Zelgen Biopharmaceuticals Co.,ltd

This was the first study in humans to test a new drug called ZGGS15 for people with advanced solid tumors that have stopped responding to standard treatments. The main goals were to check the drug's safety, see what side effects occur, and find the highest dose patients can toler…